Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Clinical trial design stories

Nov 6, 2026

Sarepta halts enrollment in confirmatory Phase 3 trial of Elevidys

Sarepta Therapeutics announced it will not enroll additional patients in the confirmatory Phase 3 trial of Elevidys, its Duchenne muscular dystrophy gene therapy, a study required to maintain the drug's accelerated approval.

Nov 6, 2026·2 sources
00
Nov 2, 2026

Novartis heart drug failure raises questions about genetic cholesterol target

The recent failure of a Novartis experimental heart drug in a large trial has raised questions among cardiologists about the widely held idea that reducing levels of genetically set cholesterol improves cardiovascular outcomes.

Nov 2, 2026·2 sources
00
Oct 23, 2026

Novartis multiple sclerosis drug remibrutinib shows weaker-than-expected relapse reduction

Novartis' oral multiple sclerosis drug remibrutinib meaningfully reduced relapses in patients but showed less efficacy than expected in phase 3 trials, potentially giving competitor Roche an advantage with its rival treatment.

Oct 23, 2026·4 sources
00
Sep 20, 2026

Alpha-lipoic acid shows early promise for progressive MS in first positive neurological MAMS trial

A multi-arm, multi-stage trial has reported positive results for alpha-lipoic acid in treating progressive multiple sclerosis, marking the first time this innovative trial design has succeeded in a neurological condition. Diabetes drug metformin was removed from the trial, though the design allows additional drugs to be tested.

Sep 20, 2026·1 source
00

Top claims

  • ▪Following the ENVISION trial closure, non-ambulatory Duchenne patients' potential pathway to Elevidys access rests on ENDEAVOR Cohort 8, an open-label Phase 1b safety study enrolling approximately 25 U.S. patients
  • ▪The U.S. FDA granted accelerated approval to Elevidys in June 2023 based on micro-dystrophin expression in skeletal muscle as a surrogate endpoint
  • ▪In July 2025, a third non-ambulatory patient death led the U.S. FDA to request a complete halt of Elevidys distribution and place clinical trials on hold

Subtopics

Drug Policy, Pricing & Approval4Clinical trials3Accelerated approval pathways1Autoimmune disease1Biomarkers & bloodwork testing1Cardiovascular diseases1Chicago1Cholesterol management1Clinical trial endpoints1Drug Approval and Clinical Trials1Drug development1Drug repurposing1Drug safety1Eli Lilly1Gene therapy1Genetic diseases1Heart health1Market competition1Neurological disorders1Pharmaceutical earnings1Pharmaceutical Industry1

Related timelines

Iran War

209 stories

Strait of Hormuz blockage

148 stories

Trump administration

161 stories

Congress

110 stories

Crypto hacks

100 stories